Uncontrolled Epstein-Barr Virus as an Atypical Presentation of Deficiency in ADA2 (DADA2)

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical immunology 2021-04, Vol.41 (3), p.680-683
Hauptverfasser:	Brooks, Joel P., Rice, Andrew J., Ji, Weizhen, Lanahan, Stephen M., Konstantino, Monica, Dara, Jasmeen, Hershfield, Michael S., Cruickshank, Amy, Dokmeci, Elif, Lakhani, Saquib, Lucas, Carrie L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Deaminase - blood Adenosine Deaminase - deficiency Antiviral Agents - therapeutic use Biomarkers Biomedical and Life Sciences Biomedicine Biopsy Child Disease Management Disease Susceptibility DNA Mutational Analysis Epstein-Barr virus Epstein-Barr Virus Infections - diagnosis Epstein-Barr Virus Infections - drug therapy Epstein-Barr Virus Infections - etiology Female Hematopoietic Stem Cell Transplantation Humans Immunology Infectious Diseases Intercellular Signaling Peptides and Proteins - blood Intercellular Signaling Peptides and Proteins - deficiency Internal Medicine Letter to Editor Medical Microbiology Severe Combined Immunodeficiency - complications Severe Combined Immunodeficiency - diagnosis Severe Combined Immunodeficiency - genetics Severe Combined Immunodeficiency - therapy Siblings Symptom Assessment Tomography, X-Ray Computed Treatment Outcome Whole Exome Sequencing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!